NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

NK cells in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after cessation of intensive chemotherapy

Intensive, combination chemotherapy for malignant diseases causes a profound immunosuppression, which persists for the whole treatment period and after its completion. Impairment of the NK cells status may increase the risk of severe, disseminated infections and cancer. The aim of the study was the...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Jarosz, M, Hak, L, Wieckiewicz, J, Balcerska, A, Mysliwska, J
Natura:	Journal article
Lingua:	English
Pubblicazione:	Termedia Publishing House Ltd. 2009

Documenti analoghi

Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
di: Amandeep Aujla, et al.
Pubblicazione: (2019-04-01)

Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
di: Ali Ghassemi, et al.
Pubblicazione: (2016-06-01)

Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
di: Miguel Enrique Cuéllar Mendoza, et al.
Pubblicazione: (2024-02-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
di: Betül Sevinir, et al.
Pubblicazione: (2011-03-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
di: Betül Sevinir, et al.
Pubblicazione: (2011-03-01)

Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy
di: Seth E. Karol, et al.
Pubblicazione: (2021-07-01)

NK cell compartment in patients with coronary heart disease.
di: Hak, Ł, et al.
Pubblicazione: (2007)

Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia
di: Darshana Jani, et al.
Pubblicazione: (2018-02-01)

Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
di: Škorić Biljana, et al.
Pubblicazione: (2020-01-01)

Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia
di: Marlise R. Luskin, et al.
Pubblicazione: (2025-02-01)

Changes in number of NK cells after one year from coronary artery bypass graft
di: Hak, L, et al.
Pubblicazione: (2009)

2448 The effect of allopurinol on pediatric patients undergoing maintenance chemotherapy for acute lymphoblastic leukemia or lymphoblastic lymphoma
di: Mariam M. Bhuiyan, et al.
Pubblicazione: (2018-06-01)

Linfoma No Hodgkin extranodal NK/T nasal Extranodal Non-Hodgkin NK/T nasal Lymphoma
di: Enrique Muñoz Hernández, et al.
Pubblicazione: (2019-05-01)

Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
di: Gustavo de Oliveira Canedo, et al.
Pubblicazione: (2025-02-01)

TO THE PROBLEM OF RADIATION-INDUCED CARCINOGENESIS AFTER TREATMENT OF HODGKIN’S LYMPHOMA AND ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND ADOLESCENTS
di: O. I. Scherbenko, et al.
Pubblicazione: (2016-02-01)

Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia
di: Le Jie Lee, et al.
Pubblicazione: (2022-01-01)

The importance of intensive chemotherapy for advanced Hodgkin lymphoma in children
di: E.S. Belyaeva, et al.
Pubblicazione: (2020-06-01)

NK cell compartment in patients with coronary heart disease
di: Siebert Janusz, et al.
Pubblicazione: (2007-05-01)

Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
di: Andrew D. Hughes, et al.
Pubblicazione: (2025-01-01)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
di: Luke Maese, et al.
Pubblicazione: (2022-06-01)

Combination chemotherapy for Hodgkin lymphoma
di: Alison J. Moskowitz
Pubblicazione: (2024-08-01)

Precursor NK cell lymphoblastic leukemia/lymphoma - report of a case with literature review
di: Sonal Jain, et al.
Pubblicazione: (2014-08-01)

The Effect of a New Glucose–Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma Cell Lines
di: Marta Woźniak, et al.
Pubblicazione: (2021-04-01)

Identification of methylation signatures associated with CAR T cell in B-cell acute lymphoblastic leukemia and non-hodgkin’s lymphoma
di: Jiwei Song, et al.
Pubblicazione: (2022-08-01)

Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma
di: Andreas Engert, et al.
Pubblicazione: (2017-12-01)

Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy
di: Ling Ling Chua, et al.
Pubblicazione: (2020-02-01)

Acute myelofibrosis superseding B‐lymphoblastic leukemia/lymphoma
di: Siba El Hussein, et al.
Pubblicazione: (2023-11-01)

Evaluation of Chemotherapy Toxicity in Acute Lymphoblastic and Myelogenous Leukemia
di: Ardeshir Ghavamzadeh, et al.
Pubblicazione: (2012-04-01)

Evaluation of Chemotherapy Toxicity in Acute Lymphoblastic and Myelogenous Leukemia
di: Taher Entezari-Maleki, et al.
Pubblicazione: (2012-06-01)

Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia
di: Keyu Liu, et al.
Pubblicazione: (2018-01-01)

Genetic Variations of Tumor Necrosis Factor –α-308 and Lymphtoxin-α+252 in Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Patients
di: Hajar Nasiri, et al.
Pubblicazione: (2013-09-01)

Hyperglycemia during induction chemotherapy of pediatric acute lymphoblastic leukemia
di: Shwetha Seetharam, et al.
Pubblicazione: (2016-01-01)

Clinical Profile and Induction Outcome of Children with T-cell Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma
di: Awais Arshed, et al.
Pubblicazione: (2022-11-01)

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib- based chemotherapy
di: Zhao J, et al.
Pubblicazione: (2015-06-01)

Participation in Physical Activity and Physical Education in School Among Children With Acute Lymphoblastic Leukemia After Intensive Chemotherapy
di: Hamidah Alias, et al.
Pubblicazione: (2019-03-01)

Ikaros Deletions among Bulgarian Patients with Acute Lymphoblastic Leukemia/Lymphoma
di: Stefan Lozenov, et al.
Pubblicazione: (2024-09-01)

Multilineage Lymphoblastic Lymphoma as an Initial Presentation of Mixed Phenotype Acute Leukemia
di: Mako Ikeda, et al.
Pubblicazione: (2023-01-01)

Methotrexate-induced chemical meningitis in patients with acute lymphoblastic leukemia/lymphoma
di: Linu A Jacob, et al.
Pubblicazione: (2015-01-01)

Sarcoid Reactions after Chemotherapy for Hodgkin's Lymphoma
di: Baldeep Wirk
Pubblicazione: (2010-01-01)

Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
di: Guillermo eGervasini, et al.
Pubblicazione: (2012-11-01)